Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration

Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration - Genetic Engineering & Biotechnology News

March 30, 2019

Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration Genetic Engineering & Biotechnology News

Eli Lilly will partner with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatments, the companies said, through an ...

Rheumatoid Arthritis Pathophysiology

Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration - Genetic Engineering & Biotechnology News

Comments

Post a Comment

Popular posts from this blog

Understanding Pulmonary Fibrosis - Hour Detroit Magazine

US revokes emergency use of malaria drugs versus coronavirus - KSTP

What’s next for rheumatoid arthritis and cannabis? - The GrowthOp